All Bausch Health articles – Page 2

  • Article

    Bausch Health Q3 revenues up 28% from Q2

    2020-11-03T17:25:00Z

    Bausch Health ’s revenues were $2,138 million in the third quarter of 2020, down by 3 percent from a year earlier both on a reported and an organic basis, as the company continued to suffer from the impact of the Covid-19 pandemic. But, compared with the second-quarter, the top ...

  • News briefs

    Bausch Health sees Q3 revenues above $2.1 bln

    2020-10-09T13:41:00Z

    Bausch Health expects third-quarter revenues to be greater than $2.1 billion, which would represent about a 28 percent increase compared to the second quarter of 2020. Revenues in the second quarter declined by 23 percent compared to the second quarter of 2019, and the company expects third-quarter sales to ...

  • bausch & Lomb
    Article

    Bausch Health to spin off its eye health unit

    2020-08-10T05:56:00Z

    Bausch Health intends to spin off its eye health business into an independent publicly traded entity. It will be an integrated, pure play eye-health company built on the Bausch + Lomb brand. The timing of the spinoff is tied to certain conditions and approvals, including the reorganization ...

  • News briefs

    ​Bausch prepares for launch of Infuse contact lenses after U.S. clearance

    2020-06-15T15:40:00Z

    Bausch + Lomb , the eyecare business of Bausch Health , is preparing to launch in the U.S. the sale of its trademark Bausch + Lomb Infuse daily disposable silicone hydrogel (SiHydaily) contact lenses in the second half of the year, after receiving clearance from the U.S. Food and Drug ...

  • Article

    Bausch Health’s Q1 revenues flat

    2020-05-10T09:07:00Z

    Bausch Health ’s sales were constrained by the Covid-19 pandemic but the global consumer and international prescription activities of its Bausch + Lomb eye care division posted strong growth. It expects a recovery from the latter part of the second quarter but nevertheless cut its full-year guidance.

  • Article

    Lawsuit widens Bausch Health’s net loss in Q4

    2020-04-05T13:20:00Z

    Bausch Health reported a net loss of $1,516 million for the fourth quarter, compared with a net loss of $344 million for the year-ago period. The management blamed mainly the accrual of legal reserves established for the resolution of a so-called “stock drop” litigation in the U.S. linked to the ...